BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 27347605)

  • 1. Quantitative Atlas of Cytochrome P450, UDP-Glucuronosyltransferase, and Transporter Proteins in Jejunum of Morbidly Obese Subjects.
    Miyauchi E; Tachikawa M; Declèves X; Uchida Y; Bouillot JL; Poitou C; Oppert JM; Mouly S; Bergmann JF; Terasaki T; Scherrmann JM; Lloret-Linares C
    Mol Pharm; 2016 Aug; 13(8):2631-40. PubMed ID: 27347605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ontogeny of Small Intestinal Drug Transporters and Metabolizing Enzymes Based on Targeted Quantitative Proteomics.
    Kiss M; Mbasu R; Nicolaï J; Barnouin K; Kotian A; Mooij MG; Kist N; Wijnen RMH; Ungell AL; Cutler P; Russel FGM; de Wildt SN
    Drug Metab Dispos; 2021 Dec; 49(12):1038-1046. PubMed ID: 34548392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro investigations into the roles of drug transporters and metabolizing enzymes in the disposition and drug interactions of dolutegravir, a HIV integrase inhibitor.
    Reese MJ; Savina PM; Generaux GT; Tracey H; Humphreys JE; Kanaoka E; Webster LO; Harmon KA; Clarke JD; Polli JW
    Drug Metab Dispos; 2013 Feb; 41(2):353-61. PubMed ID: 23132334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High Expression of UGT1A1/1A6 in Monkey Small Intestine: Comparison of Protein Expression Levels of Cytochromes P450, UDP-Glucuronosyltransferases, and Transporters in Small Intestine of Cynomolgus Monkey and Human.
    Akazawa T; Uchida Y; Miyauchi E; Tachikawa M; Ohtsuki S; Terasaki T
    Mol Pharm; 2018 Jan; 15(1):127-140. PubMed ID: 29140712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absolute protein quantification of clinically relevant cytochrome P450 enzymes and UDP-glucuronosyltransferases by mass spectrometry-based targeted proteomics.
    Gröer C; Busch D; Patrzyk M; Beyer K; Busemann A; Heidecke CD; Drozdzik M; Siegmund W; Oswald S
    J Pharm Biomed Anal; 2014 Nov; 100():393-401. PubMed ID: 25218440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mass spectrometry-based targeted proteomics method for the quantification of clinically relevant drug metabolizing enzymes in human specimens.
    Wenzel C; Drozdzik M; Oswald S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Aug; 1180():122891. PubMed ID: 34390906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Vitro Interaction of AB-FUBINACA with Human Cytochrome P450, UDP-Glucuronosyltransferase Enzymes and Drug Transporters.
    Kim S; Kim DK; Shin Y; Jeon JH; Song IS; Lee HS
    Molecules; 2020 Oct; 25(19):. PubMed ID: 33050066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative Proteomics of Clinically Relevant Drug-Metabolizing Enzymes and Drug Transporters and Their Intercorrelations in the Human Small Intestine.
    Couto N; Al-Majdoub ZM; Gibson S; Davies PJ; Achour B; Harwood MD; Carlson G; Barber J; Rostami-Hodjegan A; Warhurst G
    Drug Metab Dispos; 2020 Apr; 48(4):245-254. PubMed ID: 31959703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytochrome P450-mediated metabolism of triclosan attenuates its cytotoxicity in hepatic cells.
    Wu Y; Chitranshi P; Loukotková L; Gamboa da Costa G; Beland FA; Zhang J; Fang JL
    Arch Toxicol; 2017 Jun; 91(6):2405-2423. PubMed ID: 27896399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of Differential Tissue Abundance of Major Non-CYP Enzymes in Human.
    Basit A; Neradugomma NK; Wolford C; Fan PW; Murray B; Takahashi RH; Khojasteh SC; Smith BJ; Heyward S; Totah RA; Kelly EJ; Prasad B
    Mol Pharm; 2020 Nov; 17(11):4114-4124. PubMed ID: 32955894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Assessment of the In Vitro Inhibition of Cytochrome P450 Enzymes, UDP-Glucuronosyltransferases, and Transporters by Phosphodiester- or Phosphorothioate-Linked Oligonucleotides.
    Kazmi F; Yerino P; McCoy C; Parkinson A; Buckley DB; Ogilvie BW
    Drug Metab Dispos; 2018 Aug; 46(8):1066-1074. PubMed ID: 29735754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional Expression Levels of Drug Transporters and Metabolizing Enzymes along the Pig and Human Intestinal Tract and Comparison with Caco-2 Cells.
    Vaessen SF; van Lipzig MM; Pieters RH; Krul CA; Wortelboer HM; van de Steeg E
    Drug Metab Dispos; 2017 Apr; 45(4):353-360. PubMed ID: 28153842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3D Spheroid Primary Human Hepatocytes for Prediction of Cytochrome P450 and Drug Transporter Induction.
    Järvinen E; Hammer HS; Pötz O; Ingelman-Sundberg M; Stage TB
    Clin Pharmacol Ther; 2023 Jun; 113(6):1284-1294. PubMed ID: 36906857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous absolute protein quantification of transporters, cytochromes P450, and UDP-glucuronosyltransferases as a novel approach for the characterization of individual human liver: comparison with mRNA levels and activities.
    Ohtsuki S; Schaefer O; Kawakami H; Inoue T; Liehner S; Saito A; Ishiguro N; Kishimoto W; Ludwig-Schwellinger E; Ebner T; Terasaki T
    Drug Metab Dispos; 2012 Jan; 40(1):83-92. PubMed ID: 21994437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous Screening of Activities of Five Cytochrome P450 and Four Uridine 5'-Diphospho-glucuronosyltransferase Enzymes in Human Liver Microsomes Using Cocktail Incubation and Liquid Chromatography-Tandem Mass Spectrometry.
    Lee B; Ji HK; Lee T; Liu KH
    Drug Metab Dispos; 2015 Jul; 43(7):1137-46. PubMed ID: 25904760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysregulation of Mucosal Membrane Transporters and Drug-Metabolizing Enzymes in Ulcerative Colitis.
    Erdmann P; Bruckmueller H; Martin P; Busch D; Haenisch S; Müller J; Wiechowska-Kozlowska A; Partecke LI; Heidecke CD; Cascorbi I; Drozdzik M; Oswald S
    J Pharm Sci; 2019 Feb; 108(2):1035-1046. PubMed ID: 30267783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous quantification of the abundance of several cytochrome P450 and uridine 5'-diphospho-glucuronosyltransferase enzymes in human liver microsomes using multiplexed targeted proteomics.
    Achour B; Russell MR; Barber J; Rostami-Hodjegan A
    Drug Metab Dispos; 2014 Apr; 42(4):500-10. PubMed ID: 24408517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of hepatic UDP-glucuronosyltransferase 1A1 and 1A6 correlated with increased expression of the nuclear constitutive androstane receptor and peroxisome proliferator-activated receptor alpha in male rats fed a high-fat and high-sucrose diet.
    Osabe M; Sugatani J; Fukuyama T; Ikushiro S; Ikari A; Miwa M
    Drug Metab Dispos; 2008 Feb; 36(2):294-302. PubMed ID: 17967931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential Determinants for Metabolic Fates and Inhibitory Effects of Isobavachalcone Involving in Human Cytochrome P450, UDP-Glucuronosyltransferase Enzymes, and Efflux Transporters.
    Qin Z; Wang P; Duan S; Wan X; Xing H; Yang J; Zhang X; Yao Z; Yao X
    J Pharm Sci; 2021 May; 110(5):2285-2294. PubMed ID: 33610566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative Intra-Subject Analysis of Gene Expression and Protein Abundance of Major and Minor Drug Metabolizing Enzymes in Healthy Human Jejunum and Liver.
    Wenzel C; Lapczuk-Romanska J; Malinowski D; Ostrowski M; Drozdzik M; Oswald S
    Clin Pharmacol Ther; 2024 Feb; 115(2):221-230. PubMed ID: 37739780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.